Lundbeck

From WikiMD's Wellness Encyclopedia

Lundbeck

Lundbeck is a global pharmaceutical company specializing in brain diseases. The company is headquartered in Copenhagen, Denmark, and was founded in 1915 by Hans Lundbeck. Lundbeck is known for its focus on the research, development, production, marketing, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders.

History[edit | edit source]

Lundbeck was established in 1915 by Hans Lundbeck as a trading company. Initially, the company dealt with a variety of products, including machinery, aluminum foil, and sweeteners. In the 1920s, Lundbeck began to focus on pharmaceuticals, and by the 1950s, it had become a significant player in the pharmaceutical industry.

Research and Development[edit | edit source]

Lundbeck's research and development efforts are primarily focused on brain diseases. The company invests heavily in the development of new treatments for depression, schizophrenia, Alzheimer's disease, Parkinson's disease, and migraine. Lundbeck operates research centers in Denmark and the United States.

Products[edit | edit source]

Lundbeck has developed several well-known pharmaceuticals, including:

Corporate Structure[edit | edit source]

Lundbeck is a publicly traded company listed on the Copenhagen Stock Exchange. The company operates globally, with subsidiaries and offices in over 50 countries. Lundbeck employs approximately 5,000 people worldwide.

Corporate Social Responsibility[edit | edit source]

Lundbeck is committed to corporate social responsibility (CSR) and sustainability. The company focuses on ethical business practices, environmental sustainability, and social responsibility. Lundbeck is a member of the United Nations Global Compact and adheres to its principles.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Contributors: Prab R. Tumpati, MD